(Press-News.org) ANN ARBOR, Mich. — Millions of people with diabetes take medicine to ease the shooting, burning nerve pain that their disease can cause. And new research suggests that no matter which medicine their doctor prescribes, they'll get relief.
But some of those medicines cost nearly 10 times as much as others, apparently with no major differences in how well they ease pain, say a pair of University of Michigan Medical School experts in a new commentary in the Annals of Internal Medicine.
That makes cost -- not effect -- a crucial factor in deciding which medicine to choose for diabetic neuropathy, or diabetes nerve pain, the U-M researchers say.
Their commentary accompanies a paper from Mayo Clinic researchers and their colleagues, who analyzed a wide range of data from clinical trials of different treatments for painful diabetic neuropathy. The Mayo-led team concluded that several options appear to work well, though they need to be compared head-to-head to tell for sure which is best.
Until new studies can make those head-to-head comparisons, say the U-M experts, doctors should consider the cost of the drug, and any other conditions a patient has, when deciding what to prescribe.
Brian Callaghan, M.D., the article's first author, says the new Mayo study, national guidelines and other efforts have focused on how well different treatments work against diabetic nerve pain. Half of all people with diabetes develop neuropathy sometime during their experience with the disease, and it can keep patients from exercising or walking. Neuropathy plays a role in many diabetes complications.
But cost hasn't figured into these studies, he says. That's why he and fellow U-M neurologist Eva Feldman, M.D., Ph.D., decided to look at the dollars side of diabetic neuropathy for their article.
"These treatments all work about the same, but what's different is their side effects and cost. The older medications are an order of magnitude cheaper, about $15 to $20 a month, compared with the newer ones at nearly $200 per month," he says. "Patients are on these medications for many years, and it really starts to add up. Given that the effects of the medications are similar, why should we start patients on the expensive drugs until we've determined whether or not they respond to the less-expensive ones?"
The newer drugs, of course, have marketing campaigns behind them – and in the case of diabetic neuropathy, their manufacturers may have sought and received specific approval for diabetic neuropathy from the Food and Drug Administration.
The newer drugs have earned the highest level of recommendation in national treatment guidelines, which requires that at least 80 percent of people taking part in a clinical trial complete it in order for the study to be considered for high-level guideline approval. This helps create an artificial appearance that the newer drug is the better choice, says Callaghan.
But in fact, the trials of other medications for diabetic neuropathy had 70 percent or more completion rates, he says – not an appreciable difference.
And even though older generic drugs without a specific indication for diabetes pain must be prescribed "off label" by doctors, the evidence that they work is powerful – including the evidence from the new meta-analysis by the Mayo-led team.
Callaghan, who sees diabetic neuropathy patients at the U-M Health System, says he prescribes generic drugs, gabapentin or one of the tricyclic antidepressants, routinely as the first option for new pain.
The authors looked at the cost of one month of the typical starting dose for each of these medications. According to Drugstore.com, pregabalin is the most expensive at $189.98 per month, followed by duloxetine at $170.99 per month. Although venlafaxine is generic, its cost remains high at $119.98 per month. In contrast, gabapentin comes in at $18.99 per month, amitriptyline at $12.99 per month, and nortriptyline at $19.99 per month. A topical cream of capsaicin, available over the counter without a prescription, costs the least: $13.99 per month.
"The Mayo study supports other systematic reviews on this issue," he says. "We hope that adding in the cost consideration will be useful to neurologists and primary care physicians alike, since we all treat patients with painful diabetic neuropathy."
INFORMATION:
Callaghan, an assistant professor in the Department of Neurology, is also a member of the U-M Institute for Healthcare Policy and Innovation. Feldman is the Russell DeJong Professor of neurology and director of the A. Alfred Taubman Medical Research Institute.
Reference: Annals of Internal Medicine: Mayo study: doi:10.7326/M14-0511
U-M commentary: doi:10.7326/M14-2157
TALLAHASSEE, Fla. — A new study by a Florida State University researcher reveals that a new dietary supplement is superior to calcium and vitamin D when it comes to bone health.
Over 12 months, Bahram H. Arjmandi, Margaret A. Sitton Professor in the Department of Nutrition, Food and Exercise Sciences and Director of the Center for Advancing Exercise and Nutrition Research on Aging (CAENRA) at Florida State, studied the impact of the dietary supplement KoACT® versus calcium and vitamin D on bone loss. KoACT is a calcium-collagen chelate, a compound containing ...
A child's ability to distinguish musical rhythm is related to his or her capacity for understanding grammar, according to a recent study from a researcher at the Vanderbilt Kennedy Center.
Reyna Gordon, Ph.D., a research fellow in the Department of Otolaryngology and at the Vanderbilt Kennedy Center, is the lead author of the study that was published online recently in the journal Developmental Science. She notes that the study is the first of its kind to show an association between musical rhythm and grammar.
Though Gordon emphasizes that more research will be necessary ...
VTT Technical Research Centre of Finland has developed an innovative magnetometer that can replace conventional technology in applications such as neuroimaging, mineral exploration and molecular diagnostics. Its manufacturing costs are between 70 and 80 per cent lower than those of traditional technology, and the device is not as sensitive to external magnetic fields as its predecessors. The design of the magnetometer also makes it easier to integrate into measuring systems.
Magnetometers are sensors that measure magnetic fields or changes in magnetic fields. The kinetic ...
Although gluten-free foods are trendy among the health-conscious, they are necessary for those with celiac disease. But gluten, the primary trigger for health problems in these patients, may not be the only culprit. Scientists are reporting in ACS' Journal of Proteome Research that people with the disease also have reactions to non-gluten wheat proteins. The results could help scientists better understand how the disease works and could have implications for how to treat it.
Armin Alaedini, Susan B. Altenbach and colleagues point out that celiac disease symptoms are triggered ...
Photosynthesis is one of the most important processes in nature. The complex method by which all green plants harvest sunlight and thereby produce the oxygen in our air is still not fully understood. Researchers have used DESY's X-ray light source PETRA III to investigate a photosynthesis subsystem in a near-natural state. According to the scientists led by Privatdozentin Dr. Athina Zouni from the Humboldt University (HU) Berlin, X-ray diffraction experiments on the so-called photosystem II revealed structures which were yet unknown. The results are published in the scientific ...
Many pollutants with the potential to meddle with hormones — with bisphenol A (BPA) as a prime example — are already common in the environment. In an effort to clean up these pollutants found in the soil and waterways, scientists are now reporting a novel way to break them down by recruiting help from nanoparticles and light. The study appears in the journal ACS Applied Materials & Interfaces.
Nikhil R. Jana and Susanta Kumar Bhunia explain that the class of pollutants known as endocrine disruptors has been shown to either mimic or block hormones in animals, ...
This news release is available in Japanese.
In an article published in Frontiers in Computational Neuroscience by Okinawa Institute of Science and Technology Graduate University's Professor Robert Sinclair, he suggests that there still is a place in science in modern times for the interpretation of results using rational numbers or simple ratios. In a time where supercomputers dominate scientific analysis, Prof. Sinclair argues that there is not enough attention being paid to the basic approaches to science of the past, which were able to profoundly illuminate our ...
JRC scientists have developed a new index to measure the magnitude of heat waves, in cooperation with colleagues from five research organisations. According to the index projections, under the worst climate scenario of temperature rise nearing 4.8⁰C, extreme heat waves will become the norm by the end of the century. Heat waves like the one that hit Russia in summer 2010, the strongest on record in recent decades, will occur as often as every two years in southern Europe, North and South America, Africa and Indonesia.
The Heat Wave Magnitude Index is the first to ...
WASHINGTON, Nov. 5, 2014—A new handheld probe developed by a team of university and industry researchers in the Netherlands and France could give doctors powerful new imaging capabilities right in the palms of their hands. The imaging system, which is described in a paper published in The Optical Society's (OSA) open-access journal Optics Express, shrinks a technology that once filled a whole lab bench down to a computer screen and a small probe about the size of a stapler.
The new device combines two imaging modalities: ultrasound and photoacoustics. Ultrasound ...
If you're inside, chances are you're breathing in low levels of indoor air pollution, a mix of volatile organic compounds and other gaseous substances that can accumulate in buildings and potentially make you sick. An article in Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society, describes the latest in air-cleaning technology, including one approach based on a filter for the International Space Station.
Mitch Jacoby, a senior correspondent with C&EN, writes that in recent years, scientists have been gaining a better understanding ...
